DK173091D0 - Biologisk materiale - Google Patents

Biologisk materiale

Info

Publication number
DK173091D0
DK173091D0 DK911730A DK173091A DK173091D0 DK 173091 D0 DK173091 D0 DK 173091D0 DK 911730 A DK911730 A DK 911730A DK 173091 A DK173091 A DK 173091A DK 173091 D0 DK173091 D0 DK 173091D0
Authority
DK
Denmark
Prior art keywords
biological materials
biological
materials
Prior art date
Application number
DK911730A
Other languages
English (en)
Inventor
Mette Sommerlund
Sven Haahr
Anne Moeller-Larsen
Original Assignee
Schleroseforeningen The Danish
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schleroseforeningen The Danish filed Critical Schleroseforeningen The Danish
Priority to DK911730A priority Critical patent/DK173091D0/da
Publication of DK173091D0 publication Critical patent/DK173091D0/da
Priority to EP92921610A priority patent/EP0609305A1/en
Priority to CA002121030A priority patent/CA2121030A1/en
Priority to PCT/DK1992/000299 priority patent/WO1993007259A1/en
Priority to AU27709/92A priority patent/AU664049B2/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/285Demyelinating diseases; Multipel sclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK911730A 1991-10-11 1991-10-11 Biologisk materiale DK173091D0 (da)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DK911730A DK173091D0 (da) 1991-10-11 1991-10-11 Biologisk materiale
EP92921610A EP0609305A1 (en) 1991-10-11 1992-10-12 Type c-like human retrovirus linked to multiple sclerosis (ms)
CA002121030A CA2121030A1 (en) 1991-10-11 1992-10-12 Type c-like human retrovirus linked to multiple sclerosis (ms)
PCT/DK1992/000299 WO1993007259A1 (en) 1991-10-11 1992-10-12 Type c-like human retrovirus linked to multiple sclerosis (ms)
AU27709/92A AU664049B2 (en) 1991-10-11 1992-10-12 Type C-like human retrovirus linked to multiple sclerosis (MS)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK911730A DK173091D0 (da) 1991-10-11 1991-10-11 Biologisk materiale

Publications (1)

Publication Number Publication Date
DK173091D0 true DK173091D0 (da) 1991-10-11

Family

ID=8107599

Family Applications (1)

Application Number Title Priority Date Filing Date
DK911730A DK173091D0 (da) 1991-10-11 1991-10-11 Biologisk materiale

Country Status (5)

Country Link
EP (1) EP0609305A1 (da)
AU (1) AU664049B2 (da)
CA (1) CA2121030A1 (da)
DK (1) DK173091D0 (da)
WO (1) WO1993007259A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2715939B1 (fr) * 1994-02-04 1996-08-02 Bio Merieux Virus MSRV2 associé à la sclérose en plaques, et ses constituants nucléiques.
FR2728585A1 (fr) * 1994-12-23 1996-06-28 Bio Merieux Virus msrv1 et agent pathogene et/ou infectant msrv2 associes a la sclerose en plaques et leurs constituants nucleiques
FR2727428B1 (fr) * 1994-11-24 1997-04-30 Bio Merieux Virus msrv1 associe a la sclerose en plaques et ses constituants nucleiques
FR2715938B1 (fr) * 1994-02-04 1997-01-10 Bio Merieux Constituants nucléiques du virus MSRV1, associé à la sclérose en plaques.
FR2715936B1 (fr) * 1994-02-04 1996-04-19 Bio Merieux Virus MSRV1 associé à la sclérose en plaques, et ses constituants nucléiques.
FR2715937A1 (fr) * 1994-02-04 1995-08-11 Bio Merieux Virus MSRV1 et MSRV2 associés ensemble à la sclérose en plaques et leurs constituants nucléiques.
US6589734B1 (en) 1989-07-11 2003-07-08 Gen-Probe Incorporated Detection of HIV
US5856088A (en) * 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
FR2689520B1 (fr) 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
CA2159103C (en) * 1993-03-26 2002-03-12 Sherrol H. Mcdonough Detection of human immunodeficiency virus type 1
JPH08510136A (ja) * 1993-06-01 1996-10-29 ファフ,オルトヴィン 生体試料中のレトロウイルスの直接的かつ生化学的機能的な検出方法
DE4416300C2 (de) * 1993-06-01 1997-04-10 Ortwin Dr Faff Verfahren zum direkten und biochemisch funktionellen Nachweis von Retroviren in biologischen Proben
JPH09506428A (ja) * 1993-10-15 1997-06-24 エム. ラコウィック−ズルチェンスカー,エバ 乳癌および婦人科の癌の検出および治療
WO1995021256A1 (fr) * 1994-02-04 1995-08-10 Bio Merieux Virus msrv1 et agent pathogene et/ou infectant msrv2 associes a la sclerose en plaques, leurs constituants nucleiques et leurs applications
FR2716198B1 (fr) * 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
GB9506658D0 (en) * 1995-03-31 1995-05-24 Gatsby Charitable Foundation Plant pathogen resistance genes and uses thereof
US6287865B1 (en) 1995-03-31 2001-09-11 Plant Bioscience Limited Cf-2 plant pathogen resistance genes
FR2737500B1 (fr) 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
JP4226657B2 (ja) 1996-11-26 2009-02-18 ベーイーオー メリュー 診断、予防、及び治療のための、多発性硬化症に関連するウイルス性物質及びヌクレオチド断片
FR2765588A1 (fr) * 1997-07-07 1999-01-08 Bio Merieux Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques
DE1002138T1 (de) 1997-08-08 2001-06-07 Akzo Nobel Nv Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen
EP1068361A1 (en) * 1998-04-08 2001-01-17 MS Research A/S Diagnosis of multiple sclerosis and other demyelinating diseases
FR2788784A1 (fr) 1999-01-21 2000-07-28 Bio Merieux Fragment nucleique endogene associe a une maladie auto-immune, procede de marquage et reactif
JP4824236B2 (ja) 1999-07-09 2011-11-30 ジェン−プローブ・インコーポレーテッド 核酸増幅によるhiv−1の検出
EP2142650B1 (en) * 2007-04-10 2013-05-22 Emory University Novel hiv-1 reverse transcriptase codon deletion and its use in the management and treatment of hiv infections
CN108144745B (zh) * 2017-12-20 2020-06-16 天康生物股份有限公司 一种分离装置以及减少布氏菌病活疫苗的内毒素含量的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
EP0326395A2 (en) * 1988-01-29 1989-08-02 City Of Hope Method of detecting and identifying certain viral sequences
EP0384566A3 (en) * 1989-01-27 1991-11-13 The Wistar Institute Amplification of htlv-1 sequences from multiple sclerosis patients
WO1992008785A1 (en) * 1990-11-14 1992-05-29 The University Company Pty. Ltd. Diagnosis and treatment of multiple sclerosis

Also Published As

Publication number Publication date
AU664049B2 (en) 1995-11-02
EP0609305A1 (en) 1994-08-10
AU2770992A (en) 1993-05-03
CA2121030A1 (en) 1993-04-15
WO1993007259A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
DK39692D0 (da) Biologisk materiale
DK173091D0 (da) Biologisk materiale
FI97863B (fi) Brand- och vaermehaerdiga material
FI930259A0 (fi) Polymert piezoelektriskt material
DE69228957T2 (de) Blutverträgliches Material
DE69118371T2 (de) Tiereabschreckendes material
NO923644D0 (no) Taktekkingsmateriale
FI931966A0 (fi) Roentgenkontrastmedelskompositioner innehaollande filmbildande material
DK490388D0 (da) Materiale
DE69212780T2 (de) Selbstmetabolisierendes funktionelles Material
FI915618A0 (fi) Matningsanordning foer skoerdaraggregat.
DK150791D0 (da) Biologisk materiale
FI904816A (fi) Matningsanordning foer pulverformigt material.
DK131489D0 (da) Gastaet materiale
FI931782A0 (fi) Plog
NO920764L (no) Motstandsdyktig materiale
NO891180D0 (no) Gasstett materiale.
FI931147A0 (fi) Supraledande material
FI930245A0 (fi) Ekologisk behaollare foer foerorenande material
ITBO910422A0 (it) Materiale ceramico
NO913246D0 (no) Materiale.
NO910431D0 (no) Materiale.
DK132890D0 (da) Pudsmateriale
ITTO921029A0 (it) Provino di materiale plastico.
SE9200453D0 (sv) Temperaturisolrande konstruktionsmaterial

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
B1 Patent granted (law 1993)